BSX
Boston Scientific Corporation
Stock
$42.60−0.63 (−1.46%)Close Oct 2, 2026
- Net income, 2025
- $2.9B
- YoY, 2025
- +56.3%
Net income
Net income by fiscal year
| Period | Net income | YoY |
|---|---|---|
| 2025 | $2.9B | +56.3% |
| 2024 | $1.9B | +16.4% |
| 2023 | $1.6B | +128.2% |
| 2022 | $698M | −32.9% |
| 2021 | $1.0B | — |
| 2020 | −$82M | — |
| 2019 | $4.7B | +181.3% |
| 2018 | $1.7B | +1,506.7% |
| 2017 | $104M | −70.0% |
| 2016 | $347M | — |
| 2015 | −$239M | — |
| 2014 | −$119M | — |
| 2013 | −$121M | — |
| 2012 | −$4.1B | — |
| 2011 | $441M | — |
| 2010 | −$1.1B | — |
| 2009 | −$1.0B | — |
| 2008 | −$2.0B | — |
| 2007 | −$495M | — |